Infección por Virus de la Inmunodeficiencia Humana: Experiencia en el Hospital Infantil del Estado de Sonora de 1994 a 2007

Dorame-Castillo, Roberto; Cano-Rangel, Manuel Alberto; De Los Ángeles Durazo-A., María; Contreras-Soto, Jesús
April 2008
Boletin Clinico Hospital Infantil del Estado de Sonora;2008, Vol. 25 Issue 1, p22
Academic Journal
Objective: To make a retrospective review of patients treated for HIV (human immunodeficiency virus) carrier or AIDS in the service infectology service at the Sonora Children Hospital in 1994 thru 2007 period. Material and Methods: We reviewed the records of 25 patients diagnosed with HIV carrier or AIDS, at the Children's Hospital of Sonora. The variables considered were: age, sex, parental history, signs and symptoms, laboratory tests, treatment, the same undesirable effects and evolution. Results: Of 25 patients, 12 were male and 13 female, age range between 6 months and 16 years old, 80% of parents did not know their immune status prior to the diagnosis of their children, 93% were infected with perinatal transmission. There are currently 8 patients in the control, 7 with treatment for having burnout syndrome at the time of diagnosis, 1 without treatment because not did have a criteria to handling HIV with antiretroviral drugs. The remaining patients, 5 died from pneumonia associated to sepsis, 1 by hepatic insufficiency, 1 for rhabdomyosarcoma and one more dilated cardiomyopathy secondary to VIH. Two were discharged by age and six were transferred to other services for a variety of causes. Finally a patient did not come to control after his diagnosis. Four patients did not receive medications because the gravity did not allow. Four patients were managed at the time prior to 1996 with one or two antiretroviral drugs alone. The side effects of drugs found were only minor problems of oral intolerance that improved with the change in presentation. Conclusions: During the last 7 years the diagnosis procedure and terapeutic schemes showed a important improvement with Health National Programs


Related Articles

  • ART prevented HIV transmission in serodiscordant couples.  // Infectious Disease News;Jan2013, Vol. 26 Issue 1, p8 

    The article presents a study conducted by Chinese researchers, which showed that providing antiretroviral therapy (ART) to the HIV-positive partner in a serodiscordant couple lowered the rate of HIV transmission to the uninfected partner.

  • Enfuvirtide.  // Reactions Weekly;5/24/2008, Issue 1203, p19 

    The article describes the cases of HIV-positive patients who experienced injection-site reactions while receiving enfuvirtide-based antiretroviral regimen. The patients developed infiltrative lesions which resolved within 24 hours. Results of the histological examination are cited. A chart is...

  • Severe ADRs with ART examined in Ethiopian patients.  // Reactions Weekly;Jun2015, Vol. 1555 Issue 1, p10 

    The article presents a study which examines the severity of adverse drug reactions (ADRs) in Ethiopian adult patients with HIV/AIDS after taking antiretroviral therapy (ART).

  • HIV transmission in serodiscordant heterosexual couples. Boily, Marie-Claude; Buvé, Anne; Baggaley, Rebecca F. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/29/2010, Vol. 340 Issue 7757, p1149 

    The authors comment on a study discussed within the issue which estimated the risk of heterosexual transmission of HIV-1 from infected patients taking combined antiretroviral treatment. As stated, participants were assigned to immediate antiretroviral treatment or deferred treatment when their...

  • Pre-exposure prophylaxis in HIV. Khambhati, Ravi; Singhal, Priyanka; Marfatia, Y. S. // Indian Journal of Sexually Transmitted Diseases;2009, Vol. 30 Issue 2, p127 

    The article presents abstracts on medical topics which include a study on the use of HIV pre-exposure prophylaxis (HIV-PrEP) in HIV prevention, the efficacy of combined Tenofovir and Emtricitabine as HIV-PrEP to reduce the risk of HIV transmission in the U.S., and the impact of antiretroviral...

  • Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients. Ingle, Suzanne M.; May, Margaret T.; Gill, M. John; Mugavero, Michael J.; Lewden, Charlotte; Abgrall, Sophie; Fätkenheuer, Gerd; Reiss, Peter; Saag, Michael S.; Manzardo, Christian; Grabar, Sophie; Bruyand, Mathias; Moore, David; Mocroft, Amanda; Sterling, Timothy R.; D'Arminio Monforte, Antonella; Hernando, Victoria; Teira, Ramon; Guest, Jodie; Cavassini, Matthias // Clinical Infectious Diseases;Jul2014, Vol. 59 Issue 2, p287 

    Among HIV-infected patients who initiated antiretroviral therapy (ART), patterns of cause-specific death varied by ART duration and were strongly related to age, sex, and transmission risk group. Deaths from non-AIDS malignancies were much more frequent than those from cardiovascular...

  • Global: clinical trial shows dramatic reduction in transmission of HIV as a result of treatment. Cozac, David // HIV/AIDS Policy & Law Review;Oct2011, Vol. 15 Issue 3, p31 

    The article reports on a clinical trial conducted by the U.S. HIV Prevention Trials Network which revealed that human immunopdeficiency virus (HIV)-positive persons' adherence to an effective antiretroviral therapy reduce the risk of virus transmission by 96 percent. The trial confirmed that HIV...

  • Access to HIV/AIDS therapy widens down under.  // PharmacoEconomics & Outcomes News;6/18/2005, Issue 480, p18 

    Reports on the decision of the New Zealand drug funding agency Pharmac to provide HIV-positive persons access to the fixed combination antiretroviral agent lopinavir/ritonavir Kaletra. Plan of the agency to extend the use of antiretrovirals to help prevent mother-to-child transmission of HIV...

  • The Impact of Opiate Substitution Therapy and Highly Active Antiretroviral Therapy on Mortality Risk Among People Who Inject Drugs. Hickman, Matthew; Vickerman, Peter; Degenhardt, Louisa // Clinical Infectious Diseases;10/1/2015, Vol. 61 Issue 7, p1166 

    The authors discuss the impact of opiate substitution therapy and antiretroviral therapy on mortality risk in people who inject drugs (PWID). Topics discussed include role of opioid substitution therapy in reducing the risk of HIV transmission among PWID, role of antiretroviral therapy in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics